Tag results:

cell transplantation

Long-Term Selective Stimulation of Transplanted Neural Stem/Progenitor Cells for Spinal Cord Injury Improves Locomotor Function

[Cell Reports] In cell transplantation therapy for spinal cord injury, grafted human induced pluripotent stem cell-derived neural stem/progenitor cells (hiPSC-NS/PCs) differentiate into neurons. Scientists found that chemogenetic stimulation of hiPSC-derived neural cells enhancesd cell activity and neuron-to-neuron interactions in vitro.

Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

[Cancer Discovery] Scientists generated ex vivo drug response and multi-omics profiling data for a prospective series of 252 samples from 186 acute myeloid leukemia patients. Functional precision medicine tumor board integrated clinical, molecular and functional data for application in clinical treatment decisions.

Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation

[Journal of Clinical Oncology] Scientists reported that the risk of donor cell leukemia in allogeneic hematopoietic cell transplantation was driven by somatic myelodysplastic syndrome–associated mutations or germline predisposition in donors.

Efficient Protein Incorporation and Release by a Jigsaw-Shaped Self-Assembling Peptide Hydrogel for Injured Brain Regeneration

[Nature Communications] Investigators developed a cell-adhesive fiber-forming peptide that mimicked the jigsaw-shaped hydrophobic surface in the dovetail-packing motif of glycophorin A as an artificial ECM for regenerative therapy.

Advances in the Application of Mesenchymal Stem Cells, Exosomes, Biomimetic Materials, and 3D Printing in Osteoporosis Treatment

[Cellular & Molecular Biology Letters] Stem cells, exosomes, and biomimetic materials represent emerging technologies for osteoporosis treatment. Scientists review summarizes the latest developments in these three aspects.

Feasibility and Efficacy of Salvage Allogeneic Stem Cell Transplantation in AML Patients Relapsing after Autologous Stem Cell Transplantation

[Bone Marrow Transplantation] Investigators suggested that almost 80% of acute myeloid leukemia patients could undergo salvage therapy following relapse after front-line high-dose chemotherapy/autologous hematopoietic cell transplantation.

Popular